Healthcare -
Biotechnology - NASDAQ - US
$ 0.5008
-4.32 %
$ 61.9 M
Market Cap
-0.83
P/E
Price Target
Average
499.04%
Revenue Forecast
Estimate
38.62%
EBIT
Estimate
18.79%
Net Income
Estimate
26.80%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Mersana Therapeutics, Inc.
Wall Street analysts predict an average 1-year price target for MRSN of $3 , with forecasts ranging from
a
low of
$3 to a high of $3 .
MRSN Lowest Price Target
Wall Street Target
3 USD
499.04%
MRSN Average Price Target
Wall Street Target
3 USD
499.04%
MRSN Highest Price Target
Wall Street Target
3 USD
499.04%
REVENUE FORECAST
Revenue Forecast Chart MRSN
EBIT FORECAST
EBIT Forecast Chart MRSN
NET INCOME FORECAST
Net Income Chart MRSN